Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pathophysiologic Mechanism for MYOcarditis in COVID19 VAccinations ("MYOVAx" Study)

NCT05282498 is registered in ClinicalTrials.gov with National Heart Centre Singapore as lead sponsor.

NCT NCT05282498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05282498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pathophysiologic Mechanism for MYOcarditis in COVID19 VAccinations ("MYOVAx" Study)
Lead sponsor
National Heart Centre Singapore
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2021
Completion date
December 31, 2023
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocarditis